Standard BioTools Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $3.16 on 09/01/23, while the lowest price for the same duration was marked at $1.57 on 10/16/23.
52-week price history of LAB Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Standard BioTools Inc’s current trading price is -44.30% away from its 52-week high, while its distance from the 52-week low is 12.10%. The stock’s price range during the 52-week period has remained between $1.57 and $3.16. In the Healthcare sector, the company’s shares saw a trading volume of around 1.35 million for the day, which was evidently lower than the average daily volume of 3.2 million over the past three months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Market Capitalization and Financial Performance: An In-Depth Look
Standard BioTools Inc (LAB) has experienced a quarterly decline of -39.73% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 651.94M and boasts a workforce of 539 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.4366, with a change in price of -0.6000. Similarly, Standard BioTools Inc recorded 2,829,095 in trading volume during the last 100 days, posting a change of -25.42%.
Examining LAB’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for LAB stands at 0.16. Similarly, the long-term debt-to-equity ratio is also 0.05.
LAB Stock Stochastic Average
Standard BioTools Inc’s raw stochastic average for the past 50 days is presently 14.04%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 18.82%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 24.95% and 26.07%, respectively.
LAB Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Year to date metric has recorded a loss of -20.36%.However, over the last six months, we can see a stronger performance of -16.98%. Over the last 30 days, the price of LAB has leaped by -24.14%. And in the last five days, it has fallen by -0.56%.
